Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis

BACKGROUND: Persistence of anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis (RA) is an overall marker of treatment success. OBJECTIVE: To assess the survival of anti-TNF treatment and to define the potential predictors of drug discontinuation in RA, in order to verify the adequacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Santana, Virginia, González-Sarmiento, E, Calleja-Hernández, MA, Sánchez-Sánchez, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764953/
https://www.ncbi.nlm.nih.gov/pubmed/24023512
http://dx.doi.org/10.2147/PPA.S47453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764953/
https://www.ncbi.nlm.nih.gov/pubmed/24023512
http://dx.doi.org/10.2147/PPA.S47453

Ejemplares similares